DrugPipeline.net has announced the addition of “Global Lymphoma Drugs Market 2017 - 2021” research report to their website www.DrugPipeline.net

Bangalore, India -- (SBWire) -- 06/28/2017 --Lymphoma is a type of cancer that affects the immune system of the body. Specifically, it affects the lymphocytes, a type of white blood cell. The lymphocytes are part of the immune system and help the body to fight infections. The cancerous lymphocytes grow uncontrollably and collect in different portions of the body; lymph node can be one of the most common sites for lymphoma development. The lymph nodes are found throughout the body particularly in the groin, neck, and under the arms. Lymphoma can also develop in the deeper lymph nodes such as those in bone marrow and spleen. Very rarely this disease can start in other parts of the body such as stomach, breast, skin, brain, bowel, or liver.

Report forecast the global lymphoma drugs market to grow at a CAGR of 8.02% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global lymphoma drugs market for 2017-2021. To calculate the market size, the report considers the sales from branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Lymphoma Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Celgene
- F. Hoffmann-La Roche
- Johnson & Johnson
- Seattle Genetics

Other prominent vendors
- Amgen
- Bristol-Myers Squibb
- Gilead Sciences
- GlaxoSmithKline
- Novartis
- Pfizer
- Takeda Pharmaceuticals
- Teva Pharmaceutical Industries

Market driver
- Increase in industry-academia collaborations
- For a full, detailed list, view our report

Market challenge
- High cost of lymphoma treatment
- For a full, detailed list, view our report

Market trend
- Increasing consolidation in the cancer treatment market
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 86 pages "Global Lymphoma Drugs Market 2017 - 2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Market Introduction, Pipeline landscape, Market segmentation by disease type, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-lymphoma-drugs-market-2017-2021

Find all Healthcare Reports at - http://www.drugpipeline.net/catalog/healthcare

Related Reports;

Global Infusion Pumps Market 2017-2021 - Visit at - http://www.drugpipeline.net/technavio/global-infusion-pumps-market-2017-2021

Global Blotting Systems Market 2017-2021 - Visit at - http://www.drugpipeline.net/technavio/global-blotting-systems-market-2017-2021

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.